New Zealand - Hospital Average Length of Stay for Carcinoma in Situ
Since 2014, New Zealand Hospital Average Length of Stay for Carcinoma in Situ decreased by 8% year on year. In 2019, the country was ranked number 24 among other countries in Hospital Average Length of Stay for Carcinoma in Situ with 2.7 Days. South Korea ranked the highest with 7.5 Days in 2019, a decrease of 2.6% versus 2018. Slovakia, Latvia and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland recorded the best 5 years average growth at +10.6% per year, while New Zealand was the worst growing country at -8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 2.70 |
| 2018 | 2.80 |
| 2017 | 2.10 |
| 2016 | 4.70 |
| 2015 | 5.30 |
Download all data from 2000 to 2019
How does New Zealand rank in Hospital Average Length of Stay for Carcinoma in Situ?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
7.50 | 2019 | -2.6 % | +0.8 % | View data | |
| 2 |
#2
Slovakia
|
5.40 | 2019 | +0.0 % | +0.4 % | View data | |
| 22 |
#22
Slovenia
|
2.80 | 2019 | -6.7 % | -4.9 % | View data | |
| 24 |
#24
New Zealand
|
2.70 | 2019 | -3.6 % | -8.0 % | View data | |
| 25 |
#25
Chile
|
2.60 | 2019 | -3.7 % | -4.1 % | View data | |